Journal Logo

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid
Research papers

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Webster, Lynna,*; Jansen, Jan Peterb; Peppin, Johnc; Lasko, Bend; Irving, Gordone; Morlion, Bartf; Snidow, Jerryg; Pierce, Amyg; Mortensen, Ericg; Kleoudis, Christig; Carter, Ericg

Author Information
doi: 10.1016/j.pain.2007.11.008
  • Buy

Abstract

© 2008 Lippincott Williams & Wilkins, Inc.